Jan 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2020 Dec 31, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.17 3.51 4.50
(-9.6 pct) (-3.4 pct) (-2.4 pct)
Operating 519 mln 559 mln 650 mln
(-7.2 pct) (-0.5 pct) (+6.8 pct)
Recurring 529 mln 561 mln 650 mln
(-5.7 pct) (-2.9 pct) (+5.5 pct)
Net 341 mln 384 mln 450 mln
(-11.3 pct) (-2.4 pct) (+12.9 pct)
EPS 81.97 yen 94.23 yen 107.61 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T